mechanism	class	antibiotic	effect	id	type	mutation	gene_name	resfinder_id	card_accesssion	publications	type_of_evidence	comments	original_mutation
cell wall and envelope	beta-lactams	ampicillin	resistance	blaZ-operon	acquired multiple genes	na	blaZ;blaI;blaR1	to extract	ARO:3004197;ARO:3000160;ARO:3000217	22075588			-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M485A_pbp5_S466_ins_S	mutation combination	pbp5@M485A+pbp5@S466_ins_S	pbp5	na	na	9652435;15273117;21576454	epidemiological;mutagenesis;epidemiological	-	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M485A_pbp5_S466_ins_S_pbp5_L433_ins_D	mutation combination	pbp5@M485A+pbp5@S466_ins_S+pbp5@L433_ins_D	pbp5	na	na	9652435	epidemiological		-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M485A_pbp5_S466_ins_D	mutation combination	pbp5@M485A+pbp5@S466_ins_D	pbp5	na	na	21576454	epidemiological	-	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M485T_pbp5_S466_ins_S	mutation combination	pbp5@M485T+pbp5@S466_ins_S	pbp5	na	na	9652435;15273117	epidemiological;mutagenesis	-	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_E629V_pbp5_S466_ins_S	mutation combination	pbp5@E629V+pbp5@S466_ins_S	pbp5	na	na	15273117	mutagenesis	"""﻿The valine substitution at position 629 had little impact when it was present by itself, but it was associated with detectable increases in the MICs of all antimicrobials when it was combined with the added serine at position 466"""	-
cell wall and envelope	beta-lactams	ampicillin	undetermined_not_annotated	pbp5_S39T_pbp5_D644N	mutation combination	pbp5@S39T+pbp5@D644N	pbp5	na	na	30649343	mutagenesis	note: marked as undetermined because mutations could not be annotated, the reference amino acid does not match that of pbp5_DO.CP003583.1.fa	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M426I_pbp5_T562A_pbp5_V586L	mutation combination	pbp5@M426I+pbp5@T562A+pbp5@V586L	pbp5	na	na	8834879	cloning		-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_A558V_pbp5_T574I	mutation combination	pbp5@A558V+pbp5@T574I	pbp5	na	na	8834879	cloning		-
cell wall and envelope	beta-lactams	ampicillin	undetermined	pbp5_A401S	single mutation	pbp5@A401S	pbp5	na	na	23233485	epidemiological	note: ampicillin determinants containing pbp5@E525D, pbp5@N496K, pbp5@A499T and pbp5@A401S mutations were labelled as 'undetermined' as found in most false positives in efm_dst_dataset_v2	-
cell wall and envelope	beta-lactams	ampicillin	undetermined_not_annotated	pbp5_T499I	single mutation	pbp5@T499I	pbp5	na	na	23233485;15273117	epidemiological;mutagenesis	reported as I499T in 15273117. note: marked as undetermined because mutation could not be annotated, the reference amino acid does not match that of pbp5_DO.CP003583.1.fa	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_D325E	single mutation	pbp5@D325E	pbp5	na	na	23233485	epidemiological	-	-
cell wall and envelope	beta-lactams	ampicillin	undetermined_not_annotated	pbp5_D372E	single mutation	pbp5@D372E	pbp5	na	na	23233485	epidemiological	note: marked as undetermined because mutation could not be annotated, the reference amino acid does not match that of pbp5_DO.CP003583.1.fa	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_L610I	single mutation	pbp5@L610I	pbp5	na	na	23233485	epidemiological	-	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M485T	single mutation	pbp5@M485T	pbp5	na	na	9652435;15273117;12791845	epidemiological;mutagenesis;epidemiological	-	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M485A	single mutation	pbp5@M485A	pbp5	na	na	9652435;15273117	epidemiological;mutagenesis	-	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_S466SS	single mutation	pbp5@S466SS	pbp5	na	na	21576454;12791845	epidemiological;epidemiological		-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_S466SD	single mutation	pbp5@S466SD	pbp5	na	na	21576454;12791845	epidemiological;epidemiological		-
cell wall and envelope	beta-lactams	ampicillin	susceptibility	pbp5_*!	single mutation	pbp5@*!	pbp5	na	na	29617860	epidemiological	"""﻿We found that five of these isolates possessed insertions or stop codons in pbp5, likely resulting in non-functional proteins and the hypersusceptibility phenotypes"""	-
cell wall and envelope	beta-lactams	ampicillin	susceptibility	pbp5_K450!	single mutation	pbp5@K450!	pbp5	na	na	29617860	epidemiological	"""﻿These includedmutations that would result in stop codons after K450 andW457 in different isolates"""	-
cell wall and envelope	beta-lactams	ampicillin	susceptibility	pbp5_W457!	single mutation	pbp5@W457!	pbp5	na	na	29617860	epidemiological	"""﻿These includedmutations that would result in stop codons after K450 andW457 in different isolates"""	-
cell wall and envelope	beta-lactams	ampicillin	susceptibility	pbp5_Q192QKG	single mutation	pbp5@Q192QKG	pbp5	na	na	29617860	epidemiological	"""﻿aswell as a two codon insertion of lysine-glutamine after position 192"""	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_D434A	single mutation	pbp5@D434A	pbp5	na	na	31010813	within host evolution		-
cell wall and envelope	beta-lactams	ampicillin	undetermined	pbp5_N496K	single mutation	pbp5@N496K	pbp5	na	na	12791845	epidemiological	note: ampicillin determinants containing pbp5@E525D, pbp5@N496K, pbp5@A499T and pbp5@A401S mutations were labelled as 'undetermined' as found in most false positives in efm_dst_dataset_v2	-
cell wall and envelope	beta-lactams	ampicillin	undetermined	pbp5_A499T	single mutation	pbp5@A499T	pbp5	na	na	12791845	epidemiological	note: ampicillin determinants containing pbp5@E525D, pbp5@N496K, pbp5@A499T and pbp5@A401S mutations were labelled as 'undetermined' as found in most false positives in efm_dst_dataset_v2	-
cell wall and envelope	beta-lactams	ampicillin	undetermined	pbp5_E525D	single mutation	pbp5@E525D	pbp5	na	na	12791845	epidemiological	note: ampicillin determinants containing pbp5@E525D, pbp5@N496K, pbp5@A499T and pbp5@A401S mutations were labelled as 'undetermined' as found in most false positives in efm_dst_dataset_v2	-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_V586L	single mutation	pbp5@V586L	pbp5	na	na	12791845	epidemiological		-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_E629V	single mutation	pbp5@E629V	pbp5	na	na	12791845	epidemiological		-
cell wall and envelope	beta-lactams	ampicillin	resistance	pbp5_M426I	single mutation	pbp5@M426I	pbp5	na	na	8834879	cloning		-
cell wall and envelope	glycopeptides	teicoplanin	resistance	﻿vanA-operon	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA;vanYA;vanZA	to extract	ARO:3000236	8380148			-
cell wall and envelope	glycopeptides	teicoplanin	resistance	﻿vanA-operon-v2	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA;vanYA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	teicoplanin	resistance	﻿vanA-operon-v3	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA;vanZA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	teicoplanin	resistance	﻿vanA-operon-v4	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	teicoplanin	resistance	﻿vanA-operon-v5	acquired multiple genes	na	vanA;vanHA;vanRA;vanXA;vanYA;vanZA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	teicoplanin	undetermined	vanD-operon	acquired multiple genes	na	vanD;vanHD;vanRD;vanSD;vanXD;vanYD	to extract	ARO:3000253	12499162		note: according to 20569265, the only van operon conferring resistance to both vancomycin and teicoplain are vanA and vanD	-
cell wall and envelope	glycopeptides	vancomycin	resistance	﻿vanA-operon	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA;vanYA;vanZA	to extract	ARO:3000236	8380148		note: according to 20569265, the only van operon conferring resistance to both vancomycin and teicoplain are vanA and vanD	-
cell wall and envelope	glycopeptides	vancomycin	resistance	﻿vanA-operon-v2	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA;vanYA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	vancomycin	resistance	﻿vanA-operon-v3	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA;vanZA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	vancomycin	resistance	﻿vanA-operon-v4	acquired multiple genes	na	vanA;vanHA;vanRA;vanSA;vanXA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	vancomycin	resistance	﻿vanA-operon-v5	acquired multiple genes	na	vanA;vanHA;vanRA;vanXA;vanYA;vanZA	to extract	ARO:3000236				
cell wall and envelope	glycopeptides	vancomycin	resistance	vanB-operon	acquired multiple genes	na	vanB;vanHB;vanRB;vanSB;vanWB;vanXB;vanYB	to extract	ARO:3000238	8654967;10846225		note: according to CARD, vanB operon must have 8 genes > check	-
cell wall and envelope	glycopeptides	vancomycin	resistance	vanB-operon-v2	acquired multiple genes	na	vanB-pE7948;vanHB-pE7948;vanRB-pE7948;vanSB-pE7948;vanWB-pE7948;vanXB-pE7948;vanYB-pE7948	na	na			note: added new version of vanB operon, vanB-operon-v2, from representative isolate 10702_8#53 matching vanB operon in Enterococcus faecium isolate E7948 plasmid 3 (NZ_LR135359.1), as found in a lot of false negatives in efm_dst_dataset_v2 	
cell wall and envelope	glycopeptides	vancomycin	resistance	vanB-operon-v3	acquired multiple genes	na	vanB-pE7948;vanHB-pE7948;vanRB-pE7948;vanSB-pE7948;vanXB-pE7948;vanYB-pE7948	na	na			note: added vanB-operon-v3 as a variant of vanB-operon-v2 without vanWB-pE7948, gene found truncated in a lot of false negatives in efm_dst_dataset_v2 carrying vanB-operon-v2, and labelled as accessory by CARD	
cell wall and envelope	glycopeptides	vancomycin	resistance	vanB-operon-v4	acquired multiple genes	na	vanB;vanHB-pE7948;vanRB-pE7948;vanSB-pE7948;vanWB-pE7948;vanXB-pE7948;vanYB-pE7948	na	na			note: added vanB-operon-v4 as a variant of vanB-operon-v2 with gene vanB-pE7948 replaced by vanB, this version of vanB was found in isolates from study zhou2018 in efm_dst_dataset_v2 dataset	
cell wall and envelope	glycopeptides	vancomycin	resistance	vanB-operon-v5	acquired multiple genes	na	vanB;vanHB;vanRB_pE7948;vanSB;vanWB;vanXB;vanYB	na	na			note: added vanB-operon-v5 as a variant of vanB-operon with gene vanRB replaced by vanRB_pE7948, this version of vanB was found in isolates from study zhou2018 in efm_dst_dataset_v2 dataset	
cell wall and envelope	glycopeptides	vancomycin	resistance	vanB-operon-v6	acquired multiple genes	na	vanB-pE7948;vanHB-pE7948;vanRB-pE7948;vanSB-pE7948;vanWB-pE7948;vanXB-pE7948						
cell wall and envelope	glycopeptides	vancomycin	undetermined	﻿vanC-operon 	acquired multiple genes	na	vanC;vanRC;vanSC;vanTC;vanXYC	to extract	ARO:3000246	1416893			-
cell wall and envelope	glycopeptides	vancomycin	undetermined	vanD-operon	acquired multiple genes	na	vanD;vanHD;vanRD;vanSD;vanXD;vanYD	to extract	ARO:3000253	12499162		note: according to 20569265, the only van operon conferring resistance to both vancomycin and teicoplain are vanA and vanD	-
cell wall and envelope	glycopeptides	vancomycin	undetermined	vanE-operon	acquired multiple genes	na	vanE;vanHE;vanXE	to extract	ARO:3000259 	10471558		note: according to CARD, vanE operon must have 5 genes > check	-
cell wall and envelope	glycopeptides	vancomycin	undetermined	vanG-operon	acquired multiple genes	na	vanG;vanRG;vanSF;vanTG;vanUG;vanWG;vanXYG;vanYG	to extract	ARO:3000257	11036060; 14617152			-
cell wall and envelope	glycopeptides	vancomycin	undetermined	vanL-operon	acquired multiple genes	na	vanL;vanRL;vanSL;vanTmL;vanTrL;vanXYL	to extract	ARO:3000260	18458129			-
cell wall and envelope	glycopeptides	vancomycin	undetermined	vanM-operon	acquired multiple genes	na	vanM;vanHM;vanRM;vanSM;vanXM;vanYM	to extract	ARO:3000256	20733041			-
cell wall and envelope	glycopeptides	vancomycin	undetermined	vanN-operon	acquired multiple genes	na	vanN;vanRN;vanSN;vanTN;vanXYN	to extract	ARO:3002917	21807981			-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_cls_A20D	mutation combination	liaS@T120A+cls@A20D	liaS;cls			AMRFinder			
cell wall and envelope	lipopeptides	daptomycin	resistance	liaR_W73C	single mutation	liaR@W73C	liaR			AMRFinder			
cell wall and envelope	lipopeptides	daptomycin	resistance	liaR_WPE73CPK	single mutation	liaR@WPE73CPK	liaR			AMRFinder			
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A	single mutation	liaS@T120A	liaS			AMRFinder			
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C	mutation combination	liaS@T120A+liaR@W73C	liaS;liaR	NA	ARO:3004264;ARO:3004263	24867964;22664970	epidemiological;epidemiological	note: no other mutations extracted from 24867964 (Table S3) as they were rare (unique to single strains) and co-occurred with other mutations	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaS_H264Q_liaR_W73C	mutation combination	liaS@T120A+liaS@H264Q+liaR@W73C	liaS;liaR	NA	ARO:3004264;ARO:3004263	22664970	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaF_L31F_liaR_W73C	mutation combination	liaF@L31F+liaR@W73C	liaF;liaR	NA	ARO:3004262;ARO:3004263	21899450	epidemiological		liaF@L39F+liaR@W73C
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_N13I_liaF_I144T	mutation combination	cls@N13I+liaF@I144T	cls;liaF	NA	ARO:3003272;ARO:3004262	21899450	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_H215R_liaR_W73C	mutation combination	cls@H215R+liaR@W73C	cls;liaR	NA	ARO:3003272;ARO:3004263	21899450	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_L110_ins_MPL_liaS_T120A	mutation combination	cls@L110_ins_MPL+liaS@T120A	cls;liaS	NA	ARO:3003272;ARO:3004264	21899450	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_N13S_liaS_G92D	mutation combination	cls@N13S+liaS@G92D	cls;liaS	NA	ARO:3003272;ARO:3004264	27353469	in vitro evolution		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_cls_N13T	mutation combination	liaS@T120A+liaR@W73C+cls@N13T	liaS;liaR;cls	NA	ARO:3004264;ARO:3004263;ARO:3003272	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_cls_N13I	mutation combination	liaS@T120A+liaR@W73C+cls@N13I	liaS;liaR;cls	NA	ARO:3004264;ARO:3004263;ARO:3003273	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_cls_N13S	mutation combination	liaS@T120A+liaR@W73C+cls@N13S	liaS;liaR;cls	NA	ARO:3004264;ARO:3004263;ARO:3003274	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_cls_A20D	mutation combination	liaS@T120A+liaR@W73C+cls@A20D	liaS;liaR;cls	NA	ARO:3004264;ARO:3004263;ARO:3003275	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_cls_R218Q	mutation combination	liaS@T120A+liaR@W73C+cls@R218Q	liaS;liaR;cls	NA	ARO:3004264;ARO:3004263;ARO:3003276	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_cls_H215R	mutation combination	liaS@T120A+liaR@W73C+cls@H215R	liaS;liaR;cls	NA	ARO:3004264;ARO:3004263;ARO:3003277	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaS_N251E_cls_G53R_cls_R215K_clsB_V174G	mutation combination	liaS@N251E+cls@G53R+cls@R215K+clsB@V174G	liaS;cls;clsB	NA	to add	25963982	epidemiological	note: marked as undetermined because mutation cls@R215K could not be annotated, the reference amino acid does not match that of cls Aus0004	liaS@N251E+cls@G53R+cls@R215K+clsB@G174V
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaS_T120A_liaR_W73C_cls_N23T	mutation combination	liaS@T120A+liaR@W73C+cls@N23T	liaS;liaR;cls	NA	to add	25963982	epidemiological	note: marked as undetermined because mutation cls@N23T could not be annotated, the reference amino acid does not match that of cls Aus0004	liaS@T120A+liaR@W73C+cls@N23T
cell wall and envelope	lipopeptides	daptomycin	resistance	clsB_V38L_clsB_V174G_clsB_S298T	mutation combination	clsB@V38L+clsB@V174G+clsB@S298T	clsB	NA	to add	25963982	epidemiological		clsB@V38L+clsB@G174V+clsB@S298T
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaS_N251E_clsB_V174G	mutation combination	liaS@N251E+clsB@V174G	liaS;clsB	NA	to add	25963982	epidemiological	note: marked as undetermined because mutation liaS@N251E could not be annotated, the reference amino acid does not match that of cls Aus0004	liaS@N251E+clsB@G174V
cell wall and envelope	lipopeptides	daptomycin	resistance	clsB_V38L_clsB_V174G	mutation combination	clsB@V38L+clsB@V174G	clsB	NA	to add	25963982	epidemiological		clsB@V38L+clsB@G174V
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaS_N251E_clsB_V38L_clsB_V174G_clsB_S298T	mutation combination	liaS@N251E+clsB@V38L+clsB@V174G+clsB@S298T	liaS;clsB	NA	to add	25963982	epidemiological	note: marked as undetermined because mutation liaS@N251E could not be annotated, the reference amino acid does not match that of cls Aus0004	liaS@N251E+clsB@V38L+clsB@G174V+clsB@S298T
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_yycH_L429S	mutation combination	liaS@T120A+liaR@W73C+yycH@L429S	liaS;liaR;yycH	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	liaS@T120A+liaR@W73C+yycH@N429S
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_liaF_L31F_HDprotein_A151P	mutation combination	liaS@T120A+liaR@W73C+liaF@L31F+HDprotein@A151P	liaS;liaR;liaF;HDprotein	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	liaS@T120A+liaR@W73C+liaF@L39F+HDprotein@A151P
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_gdpD_I283F_cls_L110_ins_MPL	mutation combination	liaS@T120A+liaR@W73C+gdpD@I283F+cls@L110_ins_MPL	liaS;liaR;gdpD;cls	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_T120A_liaR_W73C_HDprotein_A151P	mutation combination	liaS@T120A+liaR@W73C+HDprotein@A151P	liaS;liaR;HDprotein	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	-
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaS_L70F_liaF_T27I_cls_G181S_cls_S455L_yycH_G386R	mutation combination	liaS@L70F+liaF@T27I+cls@G181S+cls@S455L+yycH@G386R	liaS;liaF;cls;yycH	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted. Marked as 'undertermined' because mutation yycH@G386R could not be annotated on Aus0004 liaF sequence	liaS@L70F+liaF@T35I+cls@G181S+cls@S455L+yycH@G386R
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaS_D251N_liaF_N102S_cls_N237D_cls_E279Q	mutation combination	liaS@D251N+liaF@N102S+cls@N237D+cls@E279Q	liaS;liaF;cls	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted. Marked as 'undertermined' because mutation liaF@N102S could not be annotated on Aus0004 liaF sequence	liaS@D251N+liaF@N110S+cls@N237D+cls@E279Q
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_R218Q_yycG_S333L_HDprotein_R38H	mutation combination	cls@R218Q+yycG@S333L+HDprotein@R38H	cls;yycG;HDprotein	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_R218Q_yycH_D311E_HDprotein_H35P_HDprotein_H35_del_S	mutation combination	cls@R218Q+yycH@D311E+HDprotein@H35P+HDprotein@H35_del_S	cls;yycH;HDprotein	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	cls@R218Q+yycH@D311E+HDprotein@H35P+HDprotein@?36_del_S
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_H215R_yycI_G228E	mutation combination	cls@H215R+yycI@G228E	cls;yycI	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaF_I134T_cls_N13I	mutation combination	liaF@I134T+cls@N13I	liaF;cls	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	liaF@I142T+cls@N13I
cell wall and envelope	lipopeptides	daptomycin	resistance	yycG_A414T_HDprotein_A151P	mutation combination	yycG@A414T+HDprotein@A151P	yycG;HDprotein	NA	to add	24867964	epidemiological	note: mutations in genes other than lia, cls, yyc, HD domain protein, yxd and gdpD, not extracted	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	liaF_?176_del_I_gdpD_?169_del_I	mutation combination	liaF@?176_del_I+gdpD@?169_del_I	liaF;gdpD	NA	ARO:3004262;ARO:3003802	21899450	in vitro evolution	note: only detected in Efc, thus labelled as undetermined	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	liaF_?176_del_I_gdpD_?169_del_I_cls_?60_del_K	mutation combination	liaF@?176_del_I+gdpD@?169_del_I+cls@?60_del_K	liaF;gdpD;cls	NA	ARO:3004262;ARO:3003802;ARO:3003092	21899450	in vitro evolution	note: only detected in Efc, thus labelled as undetermined	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_E192G	single mutation	liaS@E192G	liaS	NA	ARO:3004264	22664970	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	undetermined_not_annotated	liaF_L27I	single mutation	liaF@L27I	liaF	NA	ARO:3004262	22664970	epidemiological	marked as 'undertermined' as mutation coult not be annotated, reference amino acid does not match Aus0004 reference	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_R218Q	single mutation	cls@R218Q	cls	NA	ARO:3003272	21899450;24957825;23114757;30576392;23114777; 26454536	epidemiological; in vitro evolution (Efc); in vitro evolution;epidemiological;biochemical;in vivo evolution	note: initially labelled as 'undertermined' because 'The R218Q substitution in cardiolipin synthase (Cls) does not affect DAP susceptibility' according to 23114757. note: mutations other than cls not extracted from 26454536	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_H215R	single mutation	cls@H215R	cls	NA	ARO:3003272	23114777	biochemical		-
cell wall and envelope	lipopeptides	daptomycin	undetermined	yycG_S333L	single mutation	yycG@S333L	yycG	NA	not_found	23114757	epidemiological	note: yycG_S333L mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	cfa_A292G	single mutation	cfa@A292G	cfa	NA	not_found	23114757	epidemiological	note: mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	rrma_S76Y	single mutation	rrma@S76Y	rrma	NA	not_found	23114757	epidemiological	note: mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	sulP_H71Y	single mutation	sulP@H71Y	sulP	NA	not_found	23114757	epidemiological	note: mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	xpaC_H198D	single mutation	xpaC@H198D	xpaC	NA	not_found	23114757	epidemiological	note: mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	PTS-EIIA_N118K	single mutation	PTS-EIIA@N118K	PTS-EIIA	NA	not_found	23114757	epidemiological	note: mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	HDprotein_R57H	single mutation	HDprotein@R57H	HDprotein	NA	not_found	23114757	epidemiological	note: mutation co-occurred with many others in one DAP-R Efm strain	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaS_G92D	single mutation	liaS@G92D	liaS	NA	ARO:3004264	27353469	in vitro evolution		-
cell wall and envelope	lipopeptides	daptomycin	undetermined	liaF_?177_ins_I	single mutation	liaF@?177_ins_I	liaF	NA	ARO:3004262	24957825	in vitro evolution	note: only detected in Efc	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_R267H	single mutation	cls@R267H	cls	NA	ARO:3003272	24957825;26454536	in vitro evolution;in vivo evolution	note: detected both in Efc (24957825) and Efm (26454536). note: mutations other than cls not extracted from 26454536	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	cls_?76_del_NFQ	single mutation	cls@?76_del_NFQ	cls	NA	ARO:3003272	24957825	in vitro evolution	note: only detected in Efc	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	liaX_R152!	single mutation	liaX@R152!	liaX	NA	not_found	32972829	in vivo evolution	note: only detected in Efc	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_N13I	single mutation	cls@N13I	cls	NA	ARO:3003272	30576392	epidemiological		-
cell wall and envelope	lipopeptides	daptomycin	undetermined	liaR_D191N	single mutation	liaR@D191N	liaR	NA	ARO:3004263	25897118	epidemiological	note: only detected in Efc, thus labelled as undetermined	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	liaF_?176_del_I	single mutation	liaF@?176_del_I	liaF	NA	ARO:3004262	23507277;21899450	in vitro evolution;in vitro evolution	note: only detected in Efc, thus labelled as undetermined	-
cell wall and envelope	lipopeptides	daptomycin	undetermined	gdpD_?169_del_I	single mutation	gdpD@?169_del_I	gdpD	NA	ARO:3003802	21899450	in vitro evolution	note: only detected in Efc, thus labelled as undetermined	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_R211Q	single mutation	cls@R211Q	cls	NA	ARO:3003272	29195768	in vivo evolution	note: mutations other than cls and liaF not extracted from 29195768	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaF_G135A	single mutation	liaF@G135A	liaF	NA	ARO:3004262	29195768	in vivo evolution	note: mutations other than cls and liaF not extracted from 29195768	-
cell wall and envelope	lipopeptides	daptomycin	resistance	liaF_E239G	single mutation	liaF@E239G	liaF	NA	ARO:3004262	29195768	in vivo evolution	note: mutations other than cls and liaF not extracted from 29195768	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_A20D	single mutation	cls@A20D	cls	NA	ARO:3003272	26454536	in vivo evolution	note: mutations other than cls not extracted from 26454536	-
cell wall and envelope	lipopeptides	daptomycin	resistance	cls_D27N	single mutation	cls@D27N	cls	NA	ARO:3003272	26454536	in vivo evolution	note: mutations other than cls not extracted from 26454536	-
inhibit nucleic acid	quinolones	fluoroquinolones	undetermined	efmA	acquired gene	na	efmA	not_found	ARO:3003954 	19252300	cloning	seems to be a chromosomal gene (present in 90% of Efm according to CARD), it may be responsible for low level quinolone resistance, and thus the 'effect' may need to be changed	-
inhibit nucleic acid	quinolones	fluoroquinolones	undetermined	efrAB	acquired multiple genes	na	efrA;efrB	not_found	ARO:3003947	14638474	cloning	Efc chromosomal gene (present in 100% of Efc according to CARD)	-
inhibit nucleic acid	quinolones	fluoroquinolones	undetermined	emeA	acquired gene	na	emeA	not_found	ARO:3003551	11709342;24662964	mutagenesis+complementation;epidemiological	according to Table 10 in 24662964, emeA is more prevalent in CIP resistant enterococci (~75%) than in sensitive isolates (~45%)	-
inhibit nucleic acid	quinolones	fluoroquinolones	undetermined	qnr	acquired gene	na	qnr	not_found	not_found	17620379;28333351	mutagenesis+complementation;epidemiological+gene expression	"according to 28333351: ""34/35 E. faecium exhibited low-level resistance (ciprofloxacin MIC 4-32 mg/L) with no gyrA / parC mutation, but overexpressed the chromosomal Efm qnr gene"""	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R_parC_S82I	mutation combination	gyrA@S84R+parC@S82I	gyrA;parC	na	na	10508034;10103206;20006472;27790716;23986753;16517894;14769469;14616743	epidemiological;epidemiological;epidemiological;epidemiological;epidemiological;epidemiological;epidemiological;epidemiological		gyrA@S83R+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R_parC_S82R	mutation combination	gyrA@S84R+parC@S82R	gyrA;parC	na	na	20006472;27790716;16517894	epidemiological;epidemiological;epidemiological		gyrA@S83R+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R_parC_S82A	mutation combination	gyrA@S84R+parC@S82A	gyrA;parC	na	na	27790716	epidemiological		gyrA@S83R+parC@S80A
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R_parC_S82R_parC_R63G	mutation combination	gyrA@S84R+parC@S82R+parC@R63G	gyrA;parC	na	na	22228676	epidemiological		gyrA@S83R+parC@S80R+parC@R61G
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R_parC_S82I_parC_R63G	mutation combination	gyrA@S84R+parC@S82I+parC@R63G	gyrA;parC	na	na	19001448	epidemiological		gyrA@S83R+parC@S80I+parC@R61G
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R_parC_E86K 	mutation combination	gyrA@S84R+parC@E86K 	gyrA;parC	na	na	17062613	in vitro evolution		gyrA@S83R+parC@E84K 
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84I_parC_S82I	mutation combination	gyrA@S84I+parC@S82I	gyrA;parC	na	na	10103206;20006472;27790716	epidemiological;epidemiological;epidemiological		gyrA@S83I+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84I_parC_S82R	mutation combination	gyrA@S84I+parC@S82R	gyrA;parC	na	na	20006472;27790716	epidemiological;epidemiological		gyrA@S83I+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84I_gyrB_D436N_parC_S82R	mutation combination	gyrA@S84I+gyrB@D436N+parC@S82R	gyrA;gyrB;parC	na	na	23986753	epidemiological		gyrA@S83I+gyrB@?436N+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84I_parC_S82F	mutation combination	gyrA@S84I+parC@S82F	gyrA;parC	na	na	27790716	epidemiological		gyrA@S83I+parC@S80F
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y_parC_S82I	mutation combination	gyrA@S84Y+parC@S82I	gyrA;parC	na	na	10103206;20006472;27790716;23986753	epidemiological;epidemiological;epidemiological;epidemiological		gyrA@S83Y+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y_parC_S82R	mutation combination	gyrA@S84Y+parC@S82R	gyrA;parC	na	na	23986753	epidemiological		gyrA@S83Y+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y_gyrA_M128W_parC_S82I	mutation combination	gyrA@S84Y+gyrA@M128W+parC@S82I	gyrA;parC	na	na	23986753	epidemiological		gyrA@S83Y+gyrA@?127W+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y_gyrB_L371W_gyrB_P455S_parC_S82I	mutation combination	gyrA@S84Y+gyrB@L371W+gyrB@P455S+parC@S82I	gyrA;gyrB;parC	na	na	23986753	epidemiological		gyrA@S83Y+gyrB@?371W+gyrB@?455S+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y_parC_S82F	mutation combination	gyrA@S84Y+parC@S82F	gyrA;parC	na	na	27790716	epidemiological		gyrA@S83Y+parC@S80F
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y_parC_S82I_parC_R63G	mutation combination	gyrA@S84Y+parC@S82I+parC@R63G	gyrA;parC	na	na	19001448	epidemiological		gyrA@S83Y+parC@S80I+parC@R61G
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84F_parC_S82I	mutation combination	gyrA@S84F+parC@S82I	gyrA;parC	na	na	27790716;23558365	epidemiological		gyrA@S83F+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84F_parC_S82R	mutation combination	gyrA@S84F+parC@S82R	gyrA;parC	na	na	23558365	epidemiological		gyrA@S83F+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84L_parC_E86T	mutation combination	gyrA@S84L+parC@E86T	gyrA;parC	na	na	10508034	epidemiological		gyrA@S83L+parC@E84T
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_A85P_parC_S82I	mutation combination	gyrA@A85P+parC@S82I	gyrA;parC	na	na	23558365	epidemiological		gyrA@A84P+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88K_parC_S82I	mutation combination	gyrA@E88K+parC@S82I	gyrA;parC	na	na	10103206;16687591;16517894;14769469; 14616743	epidemiological;in vitro evolution;epidemiological;epidemiological;epidemiological		gyrA@E87K+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88K_parC_S82R	mutation combination	gyrA@E88K+parC@S82R	gyrA;parC	na	na	16517894	epidemiological		gyrA@E87K+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88K_parC_E86K	mutation combination	gyrA@E88K+parC@E86K	gyrA;parC	na	na	16687591	in vitro evolution		gyrA@E87K+parC@E84K
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88K_parC_S82I_parC_N75D	mutation combination	gyrA@E88K+parC@S82I+parC@N75D	gyrA;parC	na	na	23986753	epidemiological		gyrA@E87K+parC@S80I+parC@?73D
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88L_parC_S82I	mutation combination	gyrA@E88L+parC@S82I	gyrA;parC	na	na	10508034;20006472	epidemiological;epidemiological		gyrA@E87L+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88L_parC_S82R	mutation combination	gyrA@E88L+parC@S82R	gyrA;parC	na	na	10508034	epidemiological		gyrA@E87L+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88G_parC_S82I	mutation combination	gyrA@E88G+parC@S82I	gyrA;parC	na	na	27790716;16517894;14769469	epidemiological;epidemiological;epidemiological		gyrA@E87G+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88G_parC_S82R	mutation combination	gyrA@E88G+parC@S82R	gyrA;parC	na	na	16517894	epidemiological		gyrA@E87G+parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88G_parC_E86L	mutation combination	gyrA@E88G+parC@E86L	gyrA;parC	na	na	10508034	epidemiological		gyrA@E87G+parC@E84L
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88G_gyrA_S98N_parC_S82I	mutation combination	gyrA@E88G+gyrA@S98N+parC@S82I	gyrA;parC	na	na	10508034	epidemiological		gyrA@E87G+gyrA@S97N+parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R	single mutation	gyrA@S84R	gyrA	na	na	32488120;17062613	DRAGdb: literature review; in vitro evolution	warning: no citation provided	gyrA@S83R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84I	single mutation	gyrA@S84I	gyrA	na	na	32488120;17062613	DRAGdb: literature review; in vitro evolution	warning: no citation provided	gyrA@S83I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y	single mutation	gyrA@S84Y	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	gyrA@S83Y
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84F	single mutation	gyrA@S84F	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	gyrA@S83F
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84R	single mutation	gyrA@S84R	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84I	single mutation	gyrA@S84I	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_S84Y	single mutation	gyrA@S84Y	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88K	single mutation	gyrA@E88K	gyrA	na	na	16687591	in vitro evolution		gyrA@E87K
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88G	single mutation	gyrA@E88G	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	gyrA@E87G
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88Q	single mutation	gyrA@E88Q	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88G	single mutation	gyrA@E88G	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	gyrA_E88K	single mutation	gyrA@E88K	gyrA	na	na	32488120	DRAGdb: literature review	warning: no citation provided	-
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	parC_S82I	single mutation	parC@S82I	parC	na	na	10508034;16517894	epidemiological;epidemiological		parC@S80I
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	parC_S82R	single mutation	parC@S82R	parC	na	na	17062613;16517894	in vitro evolution;epidemiological		parC@S80R
inhibit nucleic acid	quinolones	fluoroquinolones	resistance	parC_E86K	single mutation	parC@E86K	parC	na	na	10508034;16517894	epidemiological;epidemiological		parC@E84K
inhibit protein synthesis	aminoglycosides	high-level_gentamicin	resistance	AAC(6')-Ie-APH(2'')-Ia	acquired gene	na	AAC(6')-Ie-APH(2'')-Ia	aac(6')-aph(2'')_1_M13771	ARO:3002597	10987725	review article		-
inhibit protein synthesis	aminoglycosides	high-level_gentamicin	resistance	AAC(6')-Ie-APH(2'')-Ia	acquired gene	na	AAC(6')-Ie-APH(2'')-Ia	aac(6')-aph(2'')_1_M13771	ARO:3002597	10987725	review article		-
inhibit protein synthesis	aminoglycosides	high-level_gentamicin	resistance	APH(2'')-IIa	acquired gene	na	APH(2'')-IIa	aph(2'')-Ib_2_AF207840;aph(2'')-Ib_3_KF652098;aph(2'')-Ib_1_AF337947	ARO:3002635	10987725	review article	note: the gene has two names, aph(2'')-Ib reported as synonym by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_gentamicin	resistance	APH(2'')-IIIa	acquired gene	na	APH(2'')-IIIa	aph(2'')-Ic_1_U51479	ARO:3002636	10987725	review article	note: the gene has two names, aph(2'')-Ic reported as synonym by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_gentamicin	resistance	APH(2'')-IVa	acquired gene	na	APH(2'')-IVa	aph(2'')-Id_1_AF016483	ARO:3002637	10987725	review article	note: the gene has two names, aph(2'')-Id reported as synonym by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_gentamicin	resistance	APH(6)-Ic	acquired gene	na	APH(6)-Ic	aph(6)-Ic_1_X01702	ARO:3002659	27420765	epidemiological	note: CARD alternative/synonym names: str sph	-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	resistance	AAC(6')-Ie-APH(2'')-Ia	acquired gene	na	AAC(6')-Ie-APH(2'')-Ia	aac(6')-aph(2'')_1_M13771	ARO:3002597	10987725	review article		-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	resistance	APH(2'')-IIa	acquired gene	na	APH(2'')-IIa	aph(2'')-Ib_2_AF207840;aph(2'')-Ib_3_KF652098;aph(2'')-Ib_1_AF337947	ARO:3002635	10987725	review article	note: the gene has two names, aph(2'')-Ib reported as synonym by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	resistance	APH(2'')-IIIa	acquired gene	na	APH(2'')-IIIa	aph(2'')-Ic_1_U51479	ARO:3002636	10987725	review article	note: the gene has two names, aph(2'')-Ic reported as synonym by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	resistance	APH(2'')-IVa	acquired gene	na	APH(2'')-IVa	aph(2'')-Id_1_AF016483	ARO:3002637	10987725	review article	note: the gene has two names, aph(2'')-Id reported as synonym by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	resistance	APH(3')-IIIa	acquired gene	na	APH(3')-IIIa	aph(3')-IIIa_1_AF330699;aph(3')-IIIa_2_AJ490186;aph(3')-IIIa_3_AB247327	ARO:3002647	10987725	review article		-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	resistance	ANT(4')-Ia	acquired gene	na	ANT(4')-Ia	aadD_2_M19465;aadD_1_AF181950	ARO:3002623	10987725	review article	note: the gene has three names, aadD and aadD2 as synonyms by CARD	-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	undetermined	AAC(6')-Ii	chromosomal gene	na	AAC(6')-Ii	aac(6')-Ii_1_L12710	ARO:3002556	10987725	review article	note: intrinsic resistance. note: high-level_kanamycin determinants AAC(6')-Ii and efmM (both core-genes) are labelled as 'undetermined' as found in a lot of false positives in efm_dst_dataset_v2	-
inhibit protein synthesis	aminoglycosides	high-level_kanamycin	undetermined	efmM	chromosomal gene	na	efmM	not_found	not_found	21159796	mutagenesis	note: high-level_kanamycin determinants AAC(6')-Ii and efmM (both core-genes) are labelled as 'undetermined' as found in a lot of false positives in efm_dst_dataset_v2	-
inhibit protein synthesis	aminoglycosides	high-level_streptomycin	resistance	ANT(3'')-Ia	acquired gene	na	ANT(3'')-Ia	ant(3'')-Ia_1_X02340	ARO:3000232	10987725	review article		-
inhibit protein synthesis	aminoglycosides	high-level_streptomycin	resistance	aad(6)	acquired gene	na	aad(6)	not_found	ARO:3002628	29617860	genotype-phenotype	note: assumbed to be the ﻿ant(6)-Ia high-level_streptomycin-resistance-conferring gene mentioned in tyson2018	
inhibit protein synthesis	aminoglycosides	high-level_streptomycin	resistance	ANT(6)-Ia	acquired gene	na	ANT(6)-Ia	ant(6)-Ia_1_AF330699	ARO:3002626	10987725	review article	note: ant(6')-Ia name used in 10987725. Also ant6 and aadE synonym names in CARD	-
inhibit protein synthesis	aminoglycosides	high-level_streptomycin	resistance	ANT(6)-Ia-pAML0157	acquired gene	na	ANT(6)-Ia-pAML0157	na	na	10987725	review article	note: ANT(6)-Ia-pAML0157 (ANT(6)-Ia I237fs 91.46 percentage identity version) and sequence added, as found in a lot of high-level_streptomycin false negatives in efm_dst_dataset_v2	
inhibit protein synthesis	aminoglycosides	high-level_streptomycin	resistance	APH(2'')-Ie	acquired gene	na	APH(2'')-Ie	aph(2'')-Ie_1_AY743255	ARO:3002634	17030911;32059020	cloning;epidemiological		-
inhibit protein synthesis	glycylcyclines	tigecycline	undetermined	tetL	acquired gene	na	tetL	tet(L)_1_HM235948;tet(L)_2_M29725;tet(L)_3_M11036;tet(L)_4_D00006;tet(L)_5_X08034;tet(L)_6_D12567;tet(L)_7_X60828;tet(L)_8_AY081910	ARO:3000179	26682961	in vitro evolution	the presence it not enough to confer TIG resistance, but a high number of copies	-
inhibit protein synthesis	glycylcyclines	tigecycline	undetermined	tetM	acquired gene	na	tetM	tet(M)_1_X92947;tet(M)_2_X90939;tet(M)_3_U08812;tet(M)_4_X75073;tet(M)_5_U58985;tet(M)_6_M21136;tet(M)_7_FN433596;tet(M)_8_X04388;tet(M)_9_X56353;tet(M)_10_EU182585;tet(M)_11_JN846696;tet(M)_12_FR671418;tet(M)_13_AM990992	ARO:3000186	26682961	in vitro evolution	the presence it not enough to confer TIG resistance, but a high number of copies	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	tetX1	acquired gene	na	tetX	tet(X)_1_GU014535;tet(X)_2_M37699;tet(X)_3_AB097942	ARO:3000205	29274469	epidemiological	resolve nomenclature and id: tetX or tetX1 --> tetX used	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_I51_del_IRATH	mutation combination	rpsJ@I51_del_IRATH	rpsJ	na	na	26364847	within host evolution	check mutation nomenclature and id	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_I51_del_I_rpsJ_Y58H	mutation combination	rpsJ@I51_del_I+rpsJ@Y58H	rpsJ	na	na	26364847	within host evolution	check mutation nomenclature and id	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_I52M_rpsJ_I52_del_RA	mutation combination	rpsJ@I52M+rpsJ@I52_del_RA	rpsJ	na	na	33122095	epidemiological	check mutation nomenclature and id	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_I52_del_RAT_rpsJ_H56N	mutation combination	rpsJ@I52_del_RAT+rpsJ@H56N	rpsJ	na	na	33122095	epidemiological	check mutation nomenclature and id	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_R53Q_rpsJ_R53_del_ATHK	mutation combination	rpsJ@R53Q+rpsJ@R53_del_ATHK	rpsJ	na	na	26124155	in vitro evolution	check mutation nomenclature and id. In the paper: R53Q-Δ54-57ATHK	-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_A54E_rpsJ_H56R	mutation combination	rpsJ@A54E+rpsJ@H56R	rpsJ	na	na	26364847	within host evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_H56R_rpsJ_K57N	mutation combination	rpsJ@H56R+rpsJ@K57N	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_K57R_rpsJ_Y58D	mutation combination	rpsJ@K57R+rpsJ@Y58D	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_A54E	single mutation	rpsJ@A54E	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_T55A	single mutation	rpsJ@T55A	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_K57E	single mutation	rpsJ@K57E	rpsJ	na	na	25348531;26124155;33122095	in vitro evolution;in vitro evolution;in vitro evolution+epidemiological		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_K57R	single mutation	rpsJ@K57R	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_Y58S	single mutation	rpsJ@Y58S	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_Y58D	single mutation	rpsJ@Y58D	rpsJ	na	na	26124155	in vitro evolution		-
inhibit protein synthesis	glycylcyclines	tigecycline	resistance	rpsJ_D60Y	single mutation	rpsJ@D60Y	rpsJ	na	na	25348531;26124155;33122095	in vitro evolution;in vitro evolution;in vitro evolution+epidemiological		-
inhibit protein synthesis	lincosamides	clindamycin	resistance	ermB	acquired gene	na	ermB	erm(B)_1_JN899585;erm(B)_2_K00551;erm(B)_6_AF242872;erm(B)_7_AF368302;erm(B)_9_AF299292;erm(B)_10_U86375;erm(B)_11_M19270;erm(B)_12_U18931;erm(B)_15_U48430;erm(B)_18_X66468;erm(B)_20_AF109075;erm(B)_21_U35228;erm(B)_22_X52632;erm(B)_26_AF080450;erm(B)_23_X72021	ARO:3000375	2997130	cloning		-
inhibit protein synthesis	lincosamides	clindamycin	resistance	ermB-E7067	acquired gene	na	ermB-E7067	na	na	2997130	cloning	note: putatively functional ermB L246fs version extracted from erythromycin-resistant isolate 10678_8#7, matching ermB in Enterococcus faecium isolate E7067 plasmid 5	
inhibit protein synthesis	lincosamides	clindamycin	resistance	ermA	acquired gene	na	ermA	erm(A)_1_X03216;erm(A)_2_AF002716;erm(A)_3_EU348758	ARO:3000347	19481372;21843202	epidemiological;epidemiological		-
inhibit protein synthesis	lincosamides	clindamycin	resistance	ermA-AF002716	acquired gene	na	ermA-AF002716	erm(A)_2_AF002716	na				-
inhibit protein synthesis	lincosamides	clindamycin	resistance	ermA-EU348758	acquired gene	na	ermA-EU348758	erm(A)_3_EU348758	na				-
inhibit protein synthesis	lincosamides	clindamycin	resistance	ermA-KT862775	acquired gene	na	ermA-KT862775	na	na				-
inhibit protein synthesis	lincosamides	clindamycin	resistance	lsaA	acquired gene	na	lsaA	lsa(A)_1_AY225127;lsa(A)_3_AY737526	ARO:3000300	12019099	cloning		-
inhibit protein synthesis	lincosamides	clindamycin	resistance	lsaB	acquired gene	na	lsaB	to extract	ARO:3003111				
inhibit protein synthesis	lincosamides	clindamycin	resistance	lsaC	acquired gene	na	lsaC	to extract	ARO:3003112				
inhibit protein synthesis	lincosamides	clindamycin	resistance	lsaE	acquired gene	na	lsaE	lsa(E)_1_JX560992	ARO:3003206	24379302	epidemiological		-
inhibit protein synthesis	lincosamides	clindamycin	resistance	lnuA	acquired gene	na	lnuA	lnu(A)_1_M14039	ARO:3002835 	29617860	weak	note: lnu genes mentioned in 29617860, but no citation provided. PubMed search resulted in 3/6 papers describing lnu genes in Efm, but co-localised with other lincosamide resistance genes	-
inhibit protein synthesis	lincosamides	clindamycin	resistance	lnuB	acquired gene	na	lnuB	lnu(B)_1_AJ238249;lnu(B)_2_JQ861959	ARO:3002836	29617860	weak	note: lnu genes mentioned in 29617860, but no citation provided. PubMed search resulted in 3/6 papers describing lnu genes in Efm, but co-localised with other lincosamide resistance genes	-
inhibit protein synthesis	lincosamides	clindamycin	resistance	lnuC	acquired gene	na	lnuC	to extract	ARO:3002837				
inhibit protein synthesis	lincosamides	clindamycin	resistance	lnuF	acquired gene	na	lnuF	to extract	ARO:3002839				
inhibit protein synthesis	lincosamides	clindamycin	undetermined	cfrA	acquired gene	na	cfrA	cfr_1_AM408573;cfr_2_AJ879565	ARO:3003441	22491691;16801432	transconjugation;in other species	note: cfr resported to confer the PhLOPS-A (Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A) in S. aures and E. coli according to 16801432, and in E. faecalis according to 22491691, but reports in Efm lacking	-
inhibit protein synthesis	lincosamides	clindamycin	resistance	eatA_T450I	single mutation	eatA@T450I	eatA	not_found	ARO:3003761	23836170	in vitro evolution		-
inhibit protein synthesis	macrolides	erythromycin	resistance	ermB	acquired gene	na	ermB	erm(B)_1_JN899585;erm(B)_2_K00551;erm(B)_6_AF242872;erm(B)_7_AF368302;erm(B)_9_AF299292;erm(B)_10_U86375;erm(B)_11_M19270;erm(B)_12_U18931;erm(B)_15_U48430;erm(B)_18_X66468;erm(B)_20_AF109075;erm(B)_21_U35228;erm(B)_22_X52632;erm(B)_26_AF080450;erm(B)_23_X72021	ARO:3000375	10722498	epidemiological		-
inhibit protein synthesis	macrolides	erythromycin	resistance	ermB-E7067	acquired gene	na	ermB-E7067	na	na	10722498	epidemiological	note: putatively functional ermB L246fs version extracted from erythromycin-resistant isolate 10678_8#7, matching ermB in Enterococcus faecium isolate E7067 plasmid 5	
inhibit protein synthesis	macrolides	erythromycin	resistance	ermA	acquired gene	na	ermA	erm(A)_1_X03216;erm(A)_2_AF002716;erm(A)_3_EU348758	ARO:3000347	10722498	epidemiological		-
inhibit protein synthesis	macrolides	erythromycin	resistance	ermA-AF002716	acquired gene	na	ermA-AF002716	erm(A)_2_AF002716	na				
inhibit protein synthesis	macrolides	erythromycin	resistance	ermA-EU348758	acquired gene	na	ermA-EU348758	erm(A)_3_EU348758	na				
inhibit protein synthesis	macrolides	erythromycin	resistance	ermA-KT862775	acquired gene	na	ermA-KT862775	na	na				
inhibit protein synthesis	macrolides	erythromycin	resistance	ermT	acquired gene	na	ermT	erm(T)_1_M64090;erm(T)_2_AY894138;erm(T)_3_AF310974;erm(T)_4_AJ488494	ARO:3000595	18285483	epidemiological		-
inhibit protein synthesis	macrolides	erythromycin	resistance	ermC	acquired gene	na	ermC	erm(C)_1_V01278;erm(C)_2_M19652;erm(C)_3_M17990;erm(C)_9_Y09001;erm(C)_10_Y09002;erm(C)_12_Y09003;erm(C)_13_M13761;erm(C)_14_M12730;erm(C)_15_U82607;erm(C)_16_AF019140	ARO:3000250	29147090;28167856;32887339	epidemiological;epidemiological;epidemiological	note: according to 29147090, ermC is mostly responsible for Intermediate resistance	-
inhibit protein synthesis	macrolides	erythromycin	undetermined	emeA	acquired gene	na	emeA	not_found	ARO:3003551	11709342	mutagenesis	"note: the role of this multidrug resistance efflux pump is not clear. According to 11709342: ""deletion of emeA led to more sensitive erythromycin"""	-
inhibit protein synthesis	macrolides	erythromycin	resistance	mefA	acquired gene	na	mefA	mef(A)_3_AF227520;mef(A)_4_HG423652;mef(A)_1_AJ971089;mef(A)_2_U83667	ARO:3000616	15870377;29055593	epidemiological;epidemiological	note: the evidence is low, found in one and two isolates respectively in only two studies	-
inhibit protein synthesis	macrolides	erythromycin	none	msrC	chromosomal gene	na	msrC	msr(C)_1_AY004350;msr(C)_2_AF313494	ARO:3002819	10722498	epidemiological	note: ermC isolated from ﻿erythromycin-susceptible, low-level-resistant, or highly resistant E. faecium strains	-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	cfrA	acquired gene	na	cfrA	cfr_1_AM408573;cfr_2_AJ879565	ARO:3003441	16801432;22203597;22491691	in other species;transconjugation;transconjugation		-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	cfrB	acquired gene	na	cfrB	cfr(B)_3_KR610408;cfr(B)_1_KM359439;cfr(B)_2_KM359438 	ARO:3004609	27893790;26248384	weak;weak	note: in 27893790, cloning of cfr(B) did not increase LNZ MIC. In 26248384, isolates also had one out of six 23S rRNA alleles mutated (G2576T), so role of individual cfr(B) gene cannot be determined	-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	optrA	acquired gene	na	optrA	optrA_1_KP399637;optrA_2_KT862781;optrA_3_KT862780;optrA_4_KT862777;optrA_5_KT862783;optrA_6_KT862784;optrA_7_KT862775;optrA_8_KT862782;optrA_9_KT892063;optrA_10_KT601170;optrA_11_KX620934;optrA_12_KX620936;optrA_13_KX620939;optrA_14_KX620941;optrA_15_KX620942;optrA_16_AMBD01000029;optrA_17_ALZI01000051;optrA_18_ALMH01000001;optrA_19_ALMN01000021;optrA_20_ALMZ01000078	ARO:3003746	25977397;26903276;27645239;28535965;27751624	transconjugation;transconjugation;epidemiological;epidemiological;epidemiological		-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	poxtA	acquired gene	na	poxtA	poxtA_1_MF095097	ARO:3004470	29635422	cloning		-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_c2437t_23SrRNA_g2589t	mutation combination	23SrRNA@c2437t+23SrRNA@g2589t	23SrRNA	not_found	not_found	25236388	in vivo evolution	note: detected in Efc	23SrRNA@g2424t+23SrRNA@g2576t
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	23SrRNA_g2589t_rplC_T150A	mutation combination	23SrRNA@g2589t+rplC@T150A	23SrRNA;rplC	not_found;not_found	not_found;not_found	28961986	epidemiological	note: detected in Efm. mutation rplC@T150A labelled as undertermined as linezolid-susceptible Efm strains (Aus0004) contain A as the reference amino acid at 150	23SrRNA@g2576t+rplC@T150A
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	23SrRNA_g2589t_rplD_F101L	mutation combination	23SrRNA@g2589t+rplD@F101L	23SrRNA;rplD	not_found;not_found	not_found;not_found	29878213	epidemiological	note: detected in Efc. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	23SrRNA@g2576t+rplD@F101L
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2589t_rplC_K95T	mutation combination	23SrRNA@g2589t+rplC@K95T	23SrRNA;rplC	not_found;not_found	not_found;not_found	29878213	epidemiological	note: detected in Efm	23SrRNA@g2576t+rplC@K95T
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_t603a_rplD_a348t	mutation combination	rplC@T201T+rplD@E116D	rplC;rplD	not_found	not_found	23880167	epidemiological	note: detected in Efc. note: marked as undetermined because mutation rplC@t603a and rplD@a348t lead to synonymous amino acid changes	rplC@t603a+rplD@c348t
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_c291t_rplC_t603a	mutation combination	rplC@?97?+rplC@T201T	rplC;rplC	not_found	not_found	23880167	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated, the reference nucleotide at position 291 in Efm is T, not C (in Efc)	rplC@c291t+rplC@t603a
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_a41c_rplC_t603a	mutation combination	rplC@Q14P+rplC@T201T	rplC;rplC	not_found	not_found	23880167	epidemiological	note: marked as undetermined because mutation rplC@t603a leads to a synonymous amino acid change	rplC@a41c+rplC@t603a
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_G4R_rplD_K8N_rplD_F101L_rplD_E202K	mutation combination	rplC@G4R+rplD@K8N+rplD@F101L+rplD@E202K	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_G4D_rplD_F101L_rplD_E202G	mutation combination	rplC@G4D+rplD@F101L+rplD@E202G	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_G4K_rplD_F101L_rplD_E202G_rplD_V203W	mutation combination	rplC@G4K+rplD@F101L+rplD@E202G+rplD@V203W	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_G4K_rplD_F101L	mutation combination	rplC@G4K+rplD@F101L	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_G4K_rplD_F101L_rplD_E201V	mutation combination	rplC@G4K+rplD@F101L+rplD@E201V	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_G4R_rplC_G7W_rplD_F101L_rplD_E202G	mutation combination	rplC@G4R+rplC@G7W+rplD@F101L+rplD@E202G	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_T150A_rplD_F101L	mutation combination	rplC@T150A+rplD@F101L	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efm. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_T150A_rplD_F101L_rplD_E202R	mutation combination	rplC@T150A+rplD@F101L+rplD@E202R	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efm. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_T150A_rplD_K8!_rplD_F101L	mutation combination	rplC@T150A+rplD@K8!+rplD@F101L	rplC;rplD	not_found	not_found	32801805	epidemiological	note: detected in Efm. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_V4G_rplD_F101L_rplD_E202G	mutation combination	rplD@V4G+rplD@F101L+rplD@E202G	rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_K8!_rplD_F101L	mutation combination	rplD@K8!+rplD@F101L	rplD	not_found	not_found	32801805	epidemiological	note: detected in Efm. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_F101L_rplD_E202R	mutation combination	rplD@F101L+rplD@E202R	rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_F101L_rplD_E202G	mutation combination	rplD@F101L+rplD@E202G	rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_F101L_rplD_V203G	mutation combination	rplD@F101L+rplD@V203G	rplD	not_found	not_found	32801805	epidemiological	note: detected in Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_t2258c	single mutation	23SrRNA@t2258c	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@t2245c
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_t2262a	single mutation	23SrRNA@t2262a	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@t2249a
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2264t	single mutation	23SrRNA@g2264t	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@g2251t
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2266a	single mutation	23SrRNA@g2266a	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@g2253a
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_c2437t	single mutation	23SrRNA@c2437t	23SrRNA	not_found	not_found	25236388	in vivo evolution	note: detected in Efc	23SrRNA@g2424t
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2460t	single mutation	23SrRNA@g2460t	23SrRNA	not_found	not_found	24566182	in vivo evolution	note: detected in Efc	23SrRNA@g2447t
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_a2463g	single mutation	23SrRNA@a2463g	23SrRNA	not_found	not_found	20100878	in vitro evolution	note: detected in Efc	23SrRNA@a2453g
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2518a	single mutation	23SrRNA@g2518a	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@g2505a
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2589a	single mutation	23SrRNA@g2589a	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@g2576a
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2589c	single mutation	23SrRNA@g2589c	23SrRNA	not_found	not_found	30339217	epidemiological	note: detected in Efm	23SrRNA@g2576c
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2634t	single mutation	23SrRNA@g2634t	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@g2621t
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2640a	single mutation	23SrRNA@g2640a	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@g2627a
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_c2659t	single mutation	23SrRNA@c2659t	23SrRNA	not_found	not_found	32117185	epidemiological	note: detected in Efc	23SrRNA@c2646t
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2589t	single mutation	23SrRNA@g2589t	23SrRNA	not_found	not_found	12234875;11408243;17436228;27873661	epidemiological+molecular;in vitro evolution;in vivo evolution;epidemiological	note: mutation reported in 60 papers (pubmed 23S rDNA search)	23SrRNA@g2576t
inhibit protein synthesis	oxazolidinones	linezolid	resistance	23SrRNA_g2518a	single mutation	23SrRNA@g2518a	23SrRNA	not_found	not_found	11408243; 17436228	in vitro evolution;in vivo evolution	note: the pubmed 23S rDNA search returned these exact two papers	23SrRNA@g2505a
inhibit protein synthesis	oxazolidinones	linezolid	resistance	rplC_K95T	single mutation	rplC@K95T	rplC	not_found	not_found	28483950	epidemiological		-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_t603a	single mutation	rplC@T201T	rplC	not_found	not_found	23880167	epidemiological	note: detected in Efc. note: marked as undetermined because mutation rplC@t603a leads to synonymous amino acid changes	rplC@t603a
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplC_S113L	single mutation	rplC@S113L	rplC	not_found	not_found	30215228	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_T35A	single mutation	rplD@T35A	rplD	not_found	not_found	30215228	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_N79D	single mutation	rplD@N79D	rplD	not_found	not_found	30215228	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_I98V	single mutation	rplD@I98V	rplD	not_found	not_found	30215228	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_F101L	single mutation	rplD@F101L	rplD	not_found	not_found	21094428;29878213;32801805	epidemiological	note: detected in Efc and Efa. mutation rplD@F101L labelled as undertermined as linezolid-susceptible Efm strains (Aus0004, DO and Com15) contain L as the reference amino acid at 101	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_Q103_del	single mutation	rplD@Q103_del	rplD	not_found	not_found	30215228	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_V109A	single mutation	rplD@V109A	rplD	not_found	not_found	32751552	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_A114V	single mutation	rplD@A114V	rplD	not_found	not_found	32751552	epidemiological	note: detected in Efc. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	rplD_N130K	single mutation	rplD@N130K	rplD	not_found	not_found	24880801;28284617;30640000;33238406	epidemiological	note: detected in Efm	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined_not_annotated	rplD_S171A	single mutation	rplD@S171A	rplD	not_found	not_found	28197728	epidemiological	note: detected in E. avium. Marked as 'undetermined' because mutation could not be annotated	-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	rplD_P171S	single mutation	rplD@P171S	rplD	not_found	not_found	24468866;24880801	epidemiological;epidemiological	note: detected in E. avium	-
inhibit protein synthesis	oxazolidinones	linezolid	resistance	rplD_a210_ins_ggt	single mutation	rplD@T70_ins_V	rplD	not_found	not_found	27893790	epidemiological	note: detected in Efm	rplD@?210_ins_ggt
inhibit protein synthesis	oxazolidinones	linezolid	resistance	rplV_A35T	single mutation	rplV@A35T	rplV	not_found	not_found	32751552	epidemiological	note: detected in Efc	-
inhibit protein synthesis	oxazolidinones	linezolid	undetermined	rplV_S77T	single mutation	rplV@S77T	rplV	not_found	not_found	29111969	epidemiological	note: detected in Efm. Note: linezolid mutation rplV@S77T labelled as 'undetermined' as found in a lot of false positives in efm_dst_dataset_v2, and in none of true positives	-
inhibit protein synthesis	streptogramins	quinupristin-dalfopristin	resistance	vatD_vgbA	acquired multiple genes	na	vatD;vgbA	vat(D)_1_L12033;vgb(A)_1_M20129	ARO:3002843;ARO:3001307	10543753	cloning		-
inhibit protein synthesis	streptogramins	streptogramin A	resistance	lsaA	acquired gene	na	lsaA	lsa(A)_1_AY225127;lsa(A)_3_AY737526	ARO:3000300	12019099	cloning		-
inhibit protein synthesis	streptogramins	streptogramin A	resistance	lsaB	acquired gene	na	lsaB	to extract	ARO:3003111				
inhibit protein synthesis	streptogramins	streptogramin A	resistance	lsaC	acquired gene	na	lsaC	to extract	ARO:3003112				
inhibit protein synthesis	streptogramins	streptogramin A	resistance	vgaD	acquired gene	na	vgaD	vga(D)_1_GQ205627	ARO:3002832	20713681	cloning		-
inhibit protein synthesis	streptogramins	streptogramin A	resistance	vatH	acquired gene	na	vatH	vat(H)_1_GQ205627	ARO:3002845	20713681	cloning		-
inhibit protein synthesis	streptogramins	streptogramin A	resistance	vatD	acquired gene	na	vatD	vat(D)_1_L12033	ARO:3002843	9812375;11600385	transconjugation;transconjugation		-
inhibit protein synthesis	streptogramins	streptogramin A	resistance	vatE	acquired gene	na	vatE	vat(E)_3_AF153312;vat(E)_5_AJ488494;vat(E)_7_AY043211;vat(E)_8_AY043209;vat(E)_9_AY043210;vat(E)_10_AY043212;vat(E)_11_AY043213	ARO:3002844	10438336;11023445	transconjugation;epidemiological?		-
inhibit protein synthesis	streptogramins	streptogramin A	undetermined	ermA	acquired gene	na	ermA	erm(A)_1_X03216;erm(A)_2_AF002716;erm(A)_3_EU348758	ARO:3000347	23076243;15574480	review article;epidemiological	note: according to 23076243, ermA is involved in MLS-A phenotype, but no citation is provided. The targeted PubMed search found only one paper where the role of ermA in streptogramin resistance is discussed ( 15574480)	-
inhibit protein synthesis	streptogramins	streptogramin A	undetermined	ermA-AF002716	acquired gene	na	ermA-AF002716	erm(A)_2_AF002716	na	23076243;15574480	review article;epidemiological	note: according to 23076243, ermA is involved in MLS-A phenotype, but no citation is provided. The targeted PubMed search found only one paper where the role of ermA in streptogramin resistance is discussed ( 15574480)	
inhibit protein synthesis	streptogramins	streptogramin A	undetermined	ermA-EU348758	acquired gene	na	ermA-EU348758	erm(A)_3_EU348758	na	23076243;15574480	review article;epidemiological	note: according to 23076243, ermA is involved in MLS-A phenotype, but no citation is provided. The targeted PubMed search found only one paper where the role of ermA in streptogramin resistance is discussed ( 15574480)	
inhibit protein synthesis	streptogramins	streptogramin A	undetermined	ermA-KT862775	acquired gene	na	ermA-KT862775	na	na	23076243;15574480	review article;epidemiological	note: according to 23076243, ermA is involved in MLS-A phenotype, but no citation is provided. The targeted PubMed search found only one paper where the role of ermA in streptogramin resistance is discussed ( 15574480)	
inhibit protein synthesis	streptogramins	streptogramin A	undetermined	cfrA	acquired gene	na	cfrA	cfr_1_AM408573;cfr_2_AJ879565	ARO:3003441	22491691;16801432	transconjugation;in other species	note: cfr resported to confer the PhLOPS-A (Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A) in S. aures and E. coli according to 16801432, and in E. faecalis according to 22491691, but reports in Efm lacking	-
inhibit protein synthesis	streptogramins	streptogramin A	undetermined	lsaE	acquired gene	na	lsaE	lsa(E)_1_JX560992	ARO:3003206	23047809;26324271	transconjugation;in other species	note: lsa(E) responsible for the LPS-A phenotype (lincosamides, pleuromutilins and streptogramin A) in S. aureus; only one report (23047809) of a transconjugant lsa(E) plasmid conferring streptogramin resistance in Efm	-
inhibit protein synthesis	streptogramins	streptogramin A	resistance	eatA_T450I	single mutation	eatA@T450I	eatA	not_found	ARO:3003761	23836170	in vitro evolution		-
inhibit protein synthesis	streptogramins	streptogramin B	resistance	lsaA	acquired gene	na	lsaA	lsa(A)_1_AY225127;lsa(A)_3_AY737526	ARO:3000300	12019099	cloning		-
inhibit protein synthesis	streptogramins	streptogramin B	resistance	lsaB	acquired gene	na	lsaB	to extract	ARO:3003111				
inhibit protein synthesis	streptogramins	streptogramin B	resistance	lsaC	acquired gene	na	lsaC	to extract	ARO:3003112				
inhibit protein synthesis	streptogramins	streptogramin B	resistance	vgbA	acquired gene	na	vgbA	vgb(A)_1_M20129	ARO:3001307	10049241;10543753	cloning		-
inhibit protein synthesis	streptogramins	streptogramin B	resistance	ermB	acquired gene	na	ermB	erm(B)_1_JN899585;erm(B)_2_K00551;erm(B)_6_AF242872;erm(B)_7_AF368302;erm(B)_9_AF299292;erm(B)_10_U86375;erm(B)_11_M19270;erm(B)_12_U18931;erm(B)_15_U48430;erm(B)_18_X66468;erm(B)_20_AF109075;erm(B)_21_U35228;erm(B)_22_X52632;erm(B)_26_AF080450;erm(B)_23_X72021	ARO:3000375	10543753	cloning		-
inhibit protein synthesis	streptogramins	streptogramin B	resistance	ermB-E7067	acquired gene	na	ermB-E7067	na	na	10543753	cloning	note: putatively functional ermB L246fs version extracted from erythromycin-resistant isolate 10678_8#7, matching ermB in Enterococcus faecium isolate E7067 plasmid 5	
inhibit protein synthesis	streptogramins	streptogramin B	undetermined	msrC	chromosomal gene	na	msrC	msr(C)_1_AY004350;msr(C)_2_AF313494	ARO:3002819	10722498; 23076243	epidemiological	note: according to  23076243, msrC confers low level to streptogramin B	-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetL	acquired gene	na	tetL	tet(L)_1_HM235948;tet(L)_2_M29725;tet(L)_3_M11036;tet(L)_4_D00006;tet(L)_5_X08034;tet(L)_6_D12567;tet(L)_7_X60828;tet(L)_8_AY081910	ARO:3000179	3118797;1854161	cloning;cloning		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetM	acquired gene	na	tetM	tet(M)_1_X92947;tet(M)_2_X90939;tet(M)_3_U08812;tet(M)_4_X75073;tet(M)_5_U58985;tet(M)_6_M21136;tet(M)_7_FN433596;tet(M)_8_X04388;tet(M)_9_X56353;tet(M)_10_EU182585;tet(M)_11_JN846696;tet(M)_12_FR671418;tet(M)_13_AM990992	ARO:3000186	1854161	cloning		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetO	acquired gene	na	tetO	tet(O)_1_M18896;tet(O)_2_M20925;tet(O)_3_Y07780	ARO:3000190	1854161	cloning		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetS	acquired gene	na	tetS	tet(S)_1_DQ377340;tet(S)_2_L09756;tet(S)_3_X92946	ARO:3000192	29617860;23233485	epidemiological;genotype-phenotype		-
inhibit protein synthesis	tetracyclines	tetracycline	undetermined	tetU	acquired gene	na	tetU	not_found	ARO:3004650	8700968	cloning	note: tetracycline determinant tetU is labelled as 'undetermined' as it is the most common gene false positives in efm_dst_dataset_v2	-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetWNW	acquired gene	na	tetWNW	not_found	ARO:3004442	23233485	genotype-phenotype		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetK	acquired gene	na	tetK	tet(K)_1_U38656;tet(K)_2_J01764	ARO:3000178	16563685	epidemiological		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetT	acquired gene	na	tetT	tet(T)_1_L42544;tet(T)_2_AY660530	not_found	15910229	epidemiological		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tetW	acquired gene	na	tetW	tet(W)_1_DQ060146;tet(W)_2_AY049983;tet(W)_3_AJ427421;tet(W)_4_FN396364;tet(W)_5_AJ427422	ARO:3000194	16751512	epidemiological		-
inhibit protein synthesis	tetracyclines	tetracycline	resistance	tet40	acquired gene	na	tet40	to extract	ARO:3000567				
inhibit protein synthesis	tetracyclines	tetracycline	undetermined	poxtA	acquired gene	na	poxtA	poxtA_1_MF095097	ARO:3004470	29635422;33238406	cloning;epidemiological	note: according to 33238406, not all poxtA-carrying isolates and transconjugants were TET resistant (see Tables 2 and 3). According to 29635422, expression of poxtA in E. faecalis was able to decrease susceptibility to phenicols, oxazolidinones and tetracyclines.	-
